600%, page-37

Akki: I suggest you do more DD on Anp.....DMD for inflammation is bigger than Sarepta who has a MC $4 billion... Sarepta with Duke Uni is only in MOUSE trials...where as Atl1102 are going into Phase 2.....re DMD trial to get the green light in early Feb.


ATL1102 for DMD - Antisense Therapeutics
PDFwww.antisense.com.au › 2017/06 › ASX...
26 Jun. 2017 · management of DMD patients is to reduce the inflammation that exacerbates the muscle fibre ... ATL1102 (injection) has successfully completed a Phase II efficacy and safety.